REPORTER: SEVEN-YEAR-OLD AIDEN SEGOOL LOOKS JUST LIKE ANY OTHER KID ABOUT TO START SCHOOL. BUT WHAT YOU CAN’T SEE IS THAT AIDEN HAS A LIFE-THREATENING ALLERGY TO DAIRY AND EGGS. >> EVERYONE GETS TO ...

Add Yahoo as a preferred source to see more of our stories on Google. If you rely on the lifesaving drug epinephrine for severe allergic reactions, the controversy over high-priced auto-injectors ...

The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...

Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...

McMaster researchers will be following a pilot project being launched in Hamilton's Jackson Square shopping mall to make epinephrine auto-injectors (EAIs) available to the public. As part of the ...

The supplemental New Drug Application (sNDA) for the 0.1mg strength was granted Priority Review by the Food and Drug Administration (FDA). The new 0.1mg strength auto-injector has a shorter needle ...

Meridian Medical Technologies, Inc., a subsidiary of King Pharmaceuticals, Inc., has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 ...

CVS Health announced Thursday morning that it has cut the price of two-packs of epinephrine auto-injectors to $109.99 — roughly the price that brand-name EpiPen shots were selling for eight years ago, ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

Auto-injector specialist Ypsomed is hopping on the U.S. manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the ...